Type 1 diabetes (T1D) patients reckon on multiple exogenous insulin infusions since their body is unable to secrete insulin (which is the primary regulator of glucose homeostasis), repercussion in prolonged elevated plasma glucose concentration (PGC). The gene discussed is INS; the disease is type 1 diabetes mellitus.